Perceived workplace and private life discrimination during legally mandated COVID-19 quarantine: Evidence from a large municipal cohort in Cologne, Germany
GMS Hygiene and Infection Control · 07.09.2026 · 21 (Doc64) · Doc64
DOI: 10.3205/dgkh000673 ↗Kurz gefasst
Fachartikel in der Zeitschrift GMS Hygiene and Infection Control, erschienen am 07.09.2026. Verfasst von Sisai Sadiq und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department for Physical Activity in Public Health, German Sports University, Institute of Movement and Neurosciences, Cologne, Germany. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aim
During the COVID-19 pandemic, quarantine measures were widely implemented and may have contributed to perceived discrimination. However, empirical evidence on its prevalence and associated factors remains limited. This study aimed to assess perceived discrimination in workplace and private contexts during quarantine and to identify associated factors.
Methods
Data from 3,853 participants of the CoCo-Fact cohort study (Cologne Corona counselling and support for index and contact persons during the quarantine period) in Cologne, Germany were analysed. Perceived discrimination was assessed using a single-item measure (yes/partly/no), complemented by qualitative free-text responses. Logistic regression models were used to identify associated factors.
Results
Perceived discrimination was reported by 5.3% of participants in the workplace and by 6.9% in private life. Workplace discrimination was primarily organisational or economic, while private-life discrimination was predominantly psychosocial. Associated factors included migrant background, higher psychological distress, and lower coping skills. Additional factors associated with private-life discrimination included younger age, higher socioeconomic status, and unemployment. The model explained 8.3% and 14.2% of the variance, respectively.
Conclusion
Although overall prevalence was low, vulnerable groups were disproportionately affected. Findings highlight the need for targeted psychosocial and structural support measures in future public health crises.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department for Physical Activity in Public Health, German Sports University, Institute of Movement and Neurosciences, Cologne, Germany.
- Institute for Occupational, Social and Environmental Medicine, Medical Faculty, RWTH Aachen University, Aachen, Germany.
- Formerly Cologne Health Department, Infektions- und Umwelthygiene, Cologne, Germany.
- Cologne Health Department, Infektions- und Umwelthygiene, Cologne, Germany.
- Augsburg District Health Department, Augsburg, Germany.
- Institute of Hygiene, University Hospital Muenster, Münster, Germany.
Zitieren
APA
Sadiq, S., Feddern, S., Graf, A. C., Grüne, B., Haberstock, L., Kossow, A., Niessen, J., Rost, S., Schmidt, N., Wiesmüller, G. A., & Joisten, C. (2026). Perceived workplace and private life discrimination during legally mandated COVID-19 quarantine: Evidence from a large municipal cohort in Cologne, Germany. GMS Hygiene and Infection Control, 21(Doc64), Doc64. https://doi.org/10.3205/dgkh000673
Vancouver
Sadiq S, Feddern S, Graf AC, Grüne B, Haberstock L, Kossow A, et al. Perceived workplace and private life discrimination during legally mandated COVID-19 quarantine: Evidence from a large municipal cohort in Cologne, Germany. GMS Hygiene and Infection Control. 2026;21(Doc64):Doc64. doi:10.3205/dgkh000673
BibTeX
@article{Sadiq2026,
author = {Sadiq, Sisai and Feddern, Sven and Graf, Anna Carlotta and Grüne, Barbara and Haberstock, Luis and Kossow, Annelene and Niessen, Johannes and Rost, Susanne and Schmidt, Nikola and Wiesmüller, Gerhard A and Joisten, Christine},
title = {Perceived workplace and private life discrimination during legally mandated COVID-19 quarantine: Evidence from a large municipal cohort in Cologne, Germany},
journal = {GMS Hygiene and Infection Control},
year = {2026},
volume = {21},
number = {Doc64},
pages = {Doc64},
doi = {10.3205/dgkh000673}
}
EUVIMED